1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate CancerMetastatic Hormone-sensitive Prostate Cancer (mHSPC)RecruitingPhase 32026-05-11NCT07241416